The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer
Open accessThe DOI matches its Crossref record; 123 of the 129 references it cites were found in a registry or an index.
Abstract
Asbestos is a naturally occurring mineral consisting of extremely fine fibres that can become trapped in the lungs after inhalation. Occupational and environmental exposures to asbestos are linked to development of lung cancer and malignant mesothelioma, a cancer of the lining surrounding the lung. This review discusses the factors that are making asbestos-induced lung cancer a continuing problem, including the extensive historic use of asbestos and decades long latency between exposure and disease development. Genomic mutations of DNA nucleotides and gene rearrangements driving lung cancer are well-studied, with biomarkers and targeted therapies already in clinical use for some of these mutations. The genes involved in these mutation biomarkers and targeted therapies are also involved in epigenetic mechanisms and are discussed in this review as it is hoped that identification of epigenetic aberrations in these genes will enable the same gene biomarkers and targeted therapies to be used. Currently, understanding of how asbestos fibres trapped in the lungs leads to epigenetic changes and lung cancer is incomplete. It has been shown that oxidoreduction reactions on fibre surfaces generate reactive oxygen species (ROS) which in turn damage DNA, leading to genetic and epigenetic alterations that reduce the activity of tumour suppressor genes. Epigenetic DNA methylation changes associated with lung cancer are summarised in this review, and some of these changes will be due to asbestos exposure. So far, little research has been carried out to separate the asbestos driven epigenetic changes from those due to non-asbestos causes of lung cancer. Asbestos-associated lung cancers exhibit less methylation variability than lung cancers in general, and in a large proportion of samples variability has been found to be restricted to promoter regions. Epigenetic aberrations in cancer are proving to be promising biomarkers for diagnosing cancers. It is hoped that further understanding of epigenetic changes in lung cancer can result in useful asbestos-associated lung cancer biomarkers to guide treatment. Research is ongoing into the detection of lung cancer epigenetic alterations using non-invasive samples of blood and sputum. These efforts hold the promise of non-invasive cancer diagnosis in the future. Efforts to reverse epigenetic aberrations in lung cancer by epigenetic therapies are ongoing but have not yet yielded success.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Üstün, Y. E. (2019) · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · Cited by 169,581
Comprehensive molecular profiling of lung adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13385 · Cited by 5,732
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
The 2015 World Health Organization Classification of Lung Tumors
Travis, W. D., Brambilla, E., Nicholson, A. G., Yatabe, Y., Austin, J. H. M., Beasley, M. B., Chirieac, L. R., Dacic, S., Duhig, E., Flieder, D. B., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000630 · Cited by 4,520
Comprehensive genomic characterization of squamous cell lung cancers
The Cancer Genome Atlas Research Network (2012) · Nature · doi:10.1038/nature11404 · Cited by 3,994
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Comprehensive genomic profiles of small cell lung cancer
George, J., Lim, J. S., Jang, S. J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., et al. (2015) · Nature · doi:10.1038/nature14664 · Cited by 2,340
Irizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.298 · Cited by 2,177
DNA methylation in cancer: too much, but also too little
Ehrlich, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205651 · Cited by 1,538
Epidemiology of ovarian cancer: a review
Brett M., R., Brett M., R., Jennifer B., P., Thomas A., S., Jennifer B., P., & Thomas A., S. (2017) · Cancer Biology & Medicine · doi:10.20892/j.issn.2095-3941.2016.0084 · Cited by 1,524
Saxonov, S., Berg, P., & Brutlag, D. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510310103 · Cited by 1,401
Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review
Bach, P. B., Mirkin, J. N., Oliver, T. K., Azzoli, C. G., Berry, D. A., Brawley, O. W., Byers, T., Colditz, G. A., Gould, M. K., Jett, J. R., et al. (2012) · JAMA · doi:10.1001/jama.2012.5521 · Cited by 1,244
Gene Body Methylation Can Alter Gene Expression and Is a Therapeutic Target in Cancer
Yang, X., Han, H., De Carvalho, D. D., Lay, F. D., Jones, P. A., & Liang, G. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.028 · Cited by 1,199 · cited 1×
“DNA methylation heterogeneity and variability are observed at distinctive genomic regions in cancer tissue.(57,58) These differentially methylated CpGs (DMCs) are consistently methylated in a non-cancer group, and variably methylated in cancer groups, with the highly variable CpGs hypothesised to contribute to tumour…”
BackgroundInflammation and cancer: An ancient link with novel potentials
Perwez Hussain, S., & Harris, C. C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23173 · Cited by 1,097
Arsenic, metals, fibres, and dusts.
(2012) · PubMed · Cited by 1,052
Increased methylation variation in epigenetic domains across cancer types
Hansen, K. D., Timp, W., Bravo, H. C., Sabunciyan, S., Langmead, B., McDonald, O. G., Wen, B., Wu, H., Liu, Y., Diep, D., et al. (2011) · Nature Genetics · doi:10.1038/ng.865 · Cited by 1,045
Yoshizawa, A., Motoi, N., Riely, G. J., Sima, C. S., Gerald, W. L., Kris, M. G., Park, B. J., Rusch, V. W., & Travis, W. D. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.232 · Cited by 976
Esteller, M., Sánchez‐Céspedes, M., Rosell, R., Sidransky, D., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 921
Predicting lung cancer by detecting aberrant promoter methylation in sputum.
Palmisano, W. A., Divine, K. K., Saccomanno, G., Gilliland, F. D., Baylin, S. B., Herman, J. G., & Belinsky, S. A. (2000) · PubMed · Cited by 891
Personal habits and indoor combustions.
(2012) · PubMed Central · Cited by 775
Juergens, R. A., Wrangle, J., Vendetti, F. P., Murphy, S. C., Zhao, M., Coleman, B., Sebree, R., Rodgers, K., Hooker, C. M., Franco, N., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0214 · Cited by 686
Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer‐Müller, S., Fong, K. M., Virmani, A. K., Geradts, J., Gazdar, A. F., & Minna, J. D. (2001) · PubMed · Cited by 608
Girmenia, C., Coco, F. L., Breccia, M., Latagliata, R., Spadea, A., D'Andrea, M., Gentile, G., Micozzi, A., Alimena, G., Martino, P., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402899 · Cited by 566
(2019) · Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) · doi:10.1200/jco · Cited by 522
INFECTIOUS COMPLICATIONS IN PATIENTS WITH ACUTE PROMYELOCITIC LEUKEMIA TREATED WITH THE AIDA REGIMEN
C, G., M, B., La Tagliata, R., Spadea, A., D'Andrea, M., P, M., Lo‐Coco, F., Gentile, G., Micozzi, A., Alimena, G., et al. (2003) · IRIS Research product catalog (Sapienza University of Rome) · doi:10.1038/sj · Cited by 510
Mok, T. S., Cheng, Y., Zhou, X., Lee, K. H., Nakagawa, K., Niho, S., Lee, M., Linke, R., Rosell, R., Corral, J., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.7994 · Cited by 439
Self-citationSozzi, G., Boeri, M., Rossi, M., Verri, C., Suatoni, P., Bravi, F., Roz, L., Conte, D., Grassi, M., Sverzellati, N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.4357 · Cited by 436
Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
Mohammad, H. P., Barbash, O., & Creasy, C. L. (2019) · Nature Medicine · doi:10.1038/s41591-019-0376-8 · Cited by 413
Translational Lung Cancer Research
(2016) · Translational Lung Cancer Research · doi:10.21037/tlcr · Cited by 412
A DNA methylation fingerprint of 1628 human samples
Fernandez, A. F., Assenov, Y., Martin-Subero, J. I., Balint, B., Siebert, R., Taniguchi, H., Yamamoto, H., Hidalgo, M., Tan, A.-C., Galm, O., et al. (2012) · Genome Research · doi:10.1101/gr.119867.110 · Cited by 411
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
Testa, U., Castelli, G., & Pelosi, E. (2018) · Cancers · doi:10.3390/cancers10080248 · Cited by 403
Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
Dutt, A., Ramos, A. H., Hammerman, P. S., Mermel, C., Cho, J., Sharifnia, T., Chande, A., Tanaka, K. E., Stransky, N., Greulich, H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020351 · Cited by 369
Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas
Virmani, A. K., Rathi, A., Zochbauer-Muller, S., Sacchi, N., Fukuyama, Y., Bryant, D., Maitra, A., Heda, S., Fong, K. M., Thunnissen, F., et al. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1303 · Cited by 355
KRAS-Mutant non-small cell lung cancer: From biology to therapy
Ferrer, I., Zugazagoitia, J., Herbertz, S., John, W., Paz-Ares, L., & Schmid-Bindert, G. (2018) · Lung Cancer · doi:10.1016/j.lungcan.2018.07.013 · Cited by 311
Wolff, H., Vehmas, T., Oksa, P., Rantanen, J., & Vainio, H. (2015) · Scandinavian Journal of Work, Environment & Health · doi:10.5271/sjweh.3462 · Cited by 289
A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
Sandoval, J., Mendez-Gonzalez, J., Nadal, E., Chen, G., Carmona, F. J., Sayols, S., Moran, S., Heyn, H., Vizoso, M., Gomez, A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5516 · Cited by 278
Molecular basis of asbestos-induced lung disease
Liu, G., Cheresh, P., & Kamp, D. W. (2013) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-163942 · Cited by 213
HER2 mutations in lung adenocarcinomas: A report from the Lung Cancer Mutation Consortium
Pillai, R. N., Behera, M., Berry, L. D., Rossi, M. R., Kris, M. G., Johnson, B. E., Bunn, P. A., Ramalingam, S. S., & Khuri, F. R. (2017) · Cancer · doi:10.1002/cncr.30869 · Cited by 209
La Fleur, L., Falk-Sörqvist, E., Smeds, P., Berglund, A., Sundström, M., Mattsson, J. S., Brandén, E., Koyi, H., Isaksson, J., Brunnström, H., et al. (2019) · Lung Cancer · doi:10.1016/j.lungcan.2019.01.003 · Cited by 207
FGFR1 Amplification in Squamous Cell Carcinoma of The Lung
Heist, R. S., Mino-Kenudson, M., Sequist, L. V., Tammireddy, S., Morrissey, L., Christiani, D. C., Engelman, J. A., & Iafrate, A. J. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826aed28 · Cited by 204
Aref-Eshghi, E., Bend, E. G., Colaiacovo, S., Caudle, M., Chakrabarti, R., Napier, M., Brick, L., Brady, L., Carere, D. A., Levy, M. A., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.03.008 · Cited by 201 · cited 1×
“Amongst all epigenetic alterations in cancer, aberrant DNA hypermethylation is more studied than aberrant hypomethylation, and diagnostic tests being developed also tend to look for hypermethylated regions rather than hypomethylated ones.(62) The reason for the focus on hypermethylation instead of hypomethylation is t…”
BackgroundGenomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung
Miyoshi, T., Umemura, S., Matsumura, Y., Mimaki, S., Tada, S., Makinoshima, H., Ishii, G., Udagawa, H., Matsumoto, S., Yoh, K., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0355 · Cited by 195
Pulmonary Endpoints (Lung Carcinomas and Asbestosis) Following Inhalation Exposure to Asbestos
Mossman, B. T., Lippmann, M., Hesterberg, T. W., Kelsey, K. T., Barchowsky, A., & Bonner, J. C. (2011) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2011.556047 · Cited by 192
Jin, G., Kim, M. J., Jeon, H.-S., Choi, J. E., Kim, D. S., Lee, E. B., Cha, S. I., Yoon, G. S., Kim, C. H., Jung, T. H., et al. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.11.012 · Cited by 185
Yatabe, Y., Kerr, K. M., Utomo, A., Rajadurai, P., Tran, V. K., Du, X., Chou, T.-Y., Enriquez, M. L. D., Lee, G. K., Iqbal, J., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000422 · Cited by 182
Schrock, A. B., Li, S. D., Frampton, G. M., Suh, J., Braun, E., Mehra, R., Buck, S. C., Bufill, J. A., Peled, N., Karim, N. A., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.03.005 · Cited by 173
Estimation of the global burden of mesothelioma deaths from incomplete national mortality data
Odgerel, C.-O., Takahashi, K., Sorahan, T., Driscoll, T., Fitzmaurice, C., Yoko-o, M., Sawanyawisuth, K., Furuya, S., Tanaka, F., Horie, S., et al. (2017) · Occupational and Environmental Medicine · doi:10.1136/oemed-2017-104298 · Cited by 160
Self-citationMolecular biomarkers for lung adenocarcinoma
Calvayrac, O., Pradines, A., Pons, E., Mazières, J., & Guibert, N. (2017) · European Respiratory Journal · doi:10.1183/13993003.01734-2016 · Cited by 158
Kao, S., Cheng, Y. Y., Williams, M., Kirschner, M. B., Madore, J., Lum, T., Sarun, K. H., Linton, A., McCaughan, B. C., Klebe, S., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.05.024 · Cited by 152
Self-citationCpG island methylation and expression of tumour-associated genes in lung carcinoma
Dammann, R., Strunnikova, M., Schagdarsurengin, U., Rastetter, M., Papritz, M., Hattenhorst, U. E., Hofmann, H., Silber, R., Burdach, S. E. G., & Hansen, G. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.02.020 · Cited by 150
Scheffler, M., Bos, M., Gardizi, M., König, K., Michels, S., Fassunke, J., Heydt, C., Künstlinger, H., Ihle, M., Ueckeroth, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2834 · Cited by 147
MAP2K1 ( MEK1 ) Mutations Define a Distinct Subset of Lung Adenocarcinoma Associated with Smoking
Arcila, M. E., Drilon, A., Sylvester, B. E., Lovly, C. M., Borsu, L., Reva, B., Kris, M. G., Solit, D. B., & Ladanyi, M. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2124 · Cited by 142
Nymark, P. E. H., Guled, M., Borze, I., Faisal, A., Lahti, L., Salmenkivi, K., Kettunen, E., Anttila, S. L., & Knuutila, S. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20880 · Cited by 141
Zhu, W., Liu, X., He, J., Chen, D., Hunag, Y., & Zhang, Y. K. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-393 · Cited by 136
DNA Methylation Biomarkers Offer Improved Diagnostic Efficiency in Lung Cancer
Nikolaidis, G., Raji, O. Y., Markopoulou, S., Gosney, J. R., Bryan, J., Warburton, C. J., Walshaw, M. J., Sheard, J., Field, J. K., & Liloglou, T. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2309 · Cited by 132
Yu, J. Q., Tao, Q., Cheng, Y. Y., Lee, K. Y., Ng, S. S. M., Cheung, K. F., Tian, L., Rha, S. Y., Neumann, U. P., Röcken, C., et al. (2008) · Cancer · doi:10.1002/cncr.23989 · Cited by 130
Self-citationCheng, Y. Y., Yu, J. Q., Wong, Y. P., Man, E. P. S., To, K. F., Jin, V. X., Li, J., Tao, Q., Sung, J. J. �., Chan, F. K. L., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603968 · Cited by 124
Self-citationAsbestos: use, bans and disease burden in Europe
Kameda, T., Takahashi, K., Kim, R., Jiang, Y., Movahed, M., Park, E.-K., & Rantanen, J. (2014) · Bulletin of the World Health Organization · doi:10.2471/blt.13.132118 · Cited by 119
Self-citationBaik, C. S., Myall, N. J., & Wakelee, H. A. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0458 · Cited by 113
Estimating the asbestos-related lung cancer burden from mesothelioma mortality
McCormack, V, Peto, J., Byrnes, G., Straif, K., & Boffetta, P. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.563 · Cited by 112
Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serum
Belinsky, S. A., Grimes, M. J., Casas, E., Stidley, C. A., Franklin, W. A., Bocklage, T. J., Johnson, D. H., & Schiller, J. H. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603721 · Cited by 109
Cowan, L. A., Talwar, S., & Yang, A. S. (2010) · Epigenomics · doi:10.2217/epi.09.44 · Cited by 98
Asbestos causes apoptosis in alveolar epithelial cells: Role of iron-induced free radicals
Aljandali, A., Pollack, H., Yeldandi, A., LI, Y., Weitzman, S. A., & Kamp, D. W. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.114826 · Cited by 92
Yang, X., Dai, W., Kwong, D. L. �., Szeto, C. Y. Y., Wong, E. H. W., Ng, W. T., Lee, A. W. M., Ngan, R. K. C., Yau, C. C., Tung, S. Y., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29192 · Cited by 91
Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors
Asiedu, M. K., Thomas, C. F., Dong, J., Schulte, S. C., Khadka, P., Sun, Z., Kosari, F., Jen, J., Molina, J. R., Vasmatzis, G., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0252 · Cited by 85
Asbestos-Induced Pulmonary Toxicity: Role of DNA Damage and Apoptosis
Upadhyay, D., & Kamp, D. W. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800602 · Cited by 83
Asbestos-Related Lung Disease: A Pictorial Review
Norbet, C., Joseph, A., Rossi, S. S., Bhalla, S., & Gutiérrez, F. R. (2014) · Current Problems in Diagnostic Radiology · doi:10.1067/j.cpradiol.2014.10.002 · Cited by 83
Gene expression profiles in asbestos-exposed epithelial and mesothelial lung cell lines
Nymark, P., Lindholm, P. M., Korpela, M. V., Lahti, L., Ruosaari, S., Kaski, S., Hollmén, J., Anttila, S., Kinnula, V. L., & Knuutila, S. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-62 · Cited by 82
Kashima, J., Kitadai, R., & Okuma, Y. (2019) · Cancers · doi:10.3390/cancers11050599 · Cited by 79
TRP channels in cell survival and cell death in normal and transformed cells
Shapovalov, G., Lehen’kyi, V., Skryma, R. N., & Prevarskaya, N. B. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.05.006 · Cited by 78
Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection
Su, Y. Y., Fang, H., & Jiang, F. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0275-5 · Cited by 78
Kirschner, M. B., Cheng, Y. Y., Armstrong, N. J., Lin, R. C. Y., Kao, S. C., Linton, A., Klebe, S., McCaughan, B. C., van Zandwijk, N., & Reid, G. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.11.007 · Cited by 77
Self-citationAccelerated Progression of Asbestos-Induced Mesotheliomas in Heterozygous p53+/- Mice
Vaslet, C. A. (2002) · Toxicological Sciences · doi:10.1093/toxsci/68.2.331 · Cited by 77
Serizawa, M., Koh, Y., Kenmotsu, H., Isaka, M., Murakami, H., Akamatsu, H., Mori, K. P., Abe, M., Hayashi, I., Taira, T., et al. (2014) · Cancer · doi:10.1002/cncr.28604 · Cited by 76
Fischer, J. R., Ohnmacht, U., Rieger, N., Žemaitis, M., Stoffregen, C., Manegold, C., & Lahm, H. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.11.016 · Cited by 76
Richards, K. L., Zhang, B., Sun, M., Dong, W., Churchill, J. D., Bachinski, L. L., Wilson, C. D., Baggerly, K., Yin, G., Hayes, D. N., et al. (2010) · Cancer · doi:10.1002/cncr.25472 · Cited by 76
Asbestos‐associated genome‐wide DNA methylation changes in lung cancer
Kettunen, E., Hernández‐Vargas, H., Cros, M., Durand, G., Calvez‐Kelm, F. L., Stuopelytė, K., Jarmalaitė, S., Salmenkivi, K., Anttila, S. L., Wolff, H. J., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30897 · Cited by 73
Xinarianos, G., McRonald, F. E., Risk, J. M., Bowers, N. L., Nikolaidis, G., Field, J. K., & Liloglou, T. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl128 · Cited by 72
Wang, Y., Yu, Z., Wang, T., Zhang, J., Hong, L., & Chen, L. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2006.12.007 · Cited by 67
Fragile Histidine Triad Gene Inactivation in Lung Cancer: The European Early Lung Cancer Project
Verri, C., Roz, L., Conte, D., Liloglou, T., Livio, A., Vesin, A., Fabbri, A., Andriani, F., Brambilla, C., Tavecchio, L., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200807-1153oc · Cited by 67
Hofman, P. M. (2017) · Cancers · doi:10.3390/cancers9080107 · Cited by 67
Kamp, D. W., Liu, G., Cheresh, P., Kim, S.-J., Mueller, A., Lam, A. P., Trejo, H., Williams, D., Tulasiram, S., Baker, M., et al. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0053oc · Cited by 65
Agents to treat BRAF-mutant lung cancer
Alvarez, J. G. B., & Otterson, G. A. (2019) · Drugs in Context · doi:10.7573/dic.212566 · Cited by 65
The Global Health Dimensions of Asbestos and Asbestos-Related Diseases
Takahashi, K., Landrigan, P. J., & Ramazzini, C. (2016) · Annals of Global Health · doi:10.1016/j.aogh.2016.01.019 · Cited by 63
Self-citationTomizawa, Y., Iijima, H., Nomoto, T., Iwasaki, Y., Otani, Y., Tsuchiya, S., Saito, R., Dobashi, K., Nakajima, T., & Mori, M. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.05.003 · Cited by 62
Nadal, E., Chen, G., Gallegos, M., Lin, L., Ferrer-Torres, D., Truini, A., Wang, Z., Lin, J., Reddy, R. M., Llatjós, R., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0736 · Cited by 62
Detection of ROS1 rearrangement in non-small cell lung cancer: current and future perspectives
Rossi, G., Jocollé, G., Conti, A., Tiseo, M., Marino, F. Z., Donati, G., Franco, R., Bono, F., Barbisan, F., & Facchinetti, F. (2017) · Lung Cancer Targets and Therapy · doi:10.2147/lctt.s120172 · Cited by 62
DNA Double-Strand Breaks by Asbestos, Silica, and Titanium Dioxide
Msiska, Z., Pacurari, M., Mishra, A., Leonard, S. S., Castranova, V., & Vallyathan, V. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0062oc · Cited by 58
Neuroplastin‐55 binds to and signals through the fibroblast growth factor receptor
Owczarek, S., Kiryushko, D. V., Larsen, M. H., Kastrup, J. S., Gajhede, M., Sandi, C., Berezin, V., Bock, E., & Soroka, V. (2009) · The FASEB Journal · doi:10.1096/fj.09-140509 · Cited by 55
Aberrant DNA methylation profiles of non-small cell lung cancers in a Korean population
Kim, D. S., Ick, S., Lee, J., Lee, Y., Choi, J. E., Kim, M., Lim, J., Lee, E. B., Kim, C., Park, T. I., et al. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.04.008 · Cited by 55
Asbestos exposure and laryngeal cancer mortality
Peng, W., Mi, J., & jiang, Y. (2015) · The Laryngoscope · doi:10.1002/lary.25693 · Cited by 55
Methylation of TMEFF2 Gene in Tissue and Serum DNA from Patients with Non-Small Cell Lung Cancer
Lee, S. M., Park, J. Y., & Kim, D. S. (2012) · Molecules and Cells · doi:10.1007/s10059-012-0083-5 · Cited by 53
Johnson, T. G., Schelch, K., Cheng, Y. Y., Williams, M., Sarun, K. H., Kirschner, M. B., Kao, S., Linton, A., Klebe, S., McCaughan, B. C., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.10.016 · Cited by 53
Self-citationBurmeister, B., Schwerdtle, T., Poser, I., Hoffmann, E., Hartwig, A., Müller, W.-U., Rettenmeier, A. W., Seemayer, N. H., & Dopp, E. (2004) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2003.11.003 · Cited by 52
FGFR1 inhibition in lung squamous cell carcinoma: questions and controversies
Weeden, C. E., Solomon, B., & Asselin-Labat, M.-L. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.49 · Cited by 47
Distribution of KRAS, DDR2, and TP53 gene mutations in lung cancer: An analysis of Iranian patients
Fathi, Z., Mousavi, S. A., Roudi, R., & Ghazi, F. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200633 · Cited by 45
Saulnier, A., Vaissière, T., Yue, J., Siouda, M., Malfroy, M., Accardi, R., Creveaux, M., Sebastian, S., Shahzad, N., Gheit, T., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26299 · Cited by 43
Management of EGFR mutated nonsmall cell lung carcinoma patients
Grigoriu, B. D., Berghmans, T., & Meert, A. (2015) · European Respiratory Journal · doi:10.1183/09031936.00156614 · Cited by 43
Nagji, A. S., Liu, Y., Stelow, E. B., Stukenborg, G. J., & Jones, D. R. (2010) · The Journal of Pathology · doi:10.1002/path.2707 · Cited by 39
ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes
Joshi, A., Pande, N., Noronha, V., Patil, V., Kumar, R., Chougule, A., Trivedi, V., Janu, A., Mahajan, A., & Prabhash, K. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.900 · Cited by 37
Cui, J., Li, W., Han, F., & Liu, Y. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2015.02.05 · Cited by 35
TPO genetic variants and risk of differentiated thyroid carcinoma in two European populations
Cipollini, M., Pastor, S., Gemignani, F., Castell, J., Garritano, S., Bonotti, A., Biarnés, J., Figlioli, G., Romei, C., Marcos, R., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28317 · Cited by 34
Screening and Early Detection of Lung Cancer
Eggert, J. A., Palavanzadeh, M., & Blanton, A. (2017) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2017.03.001 · Cited by 34
Mutant AKT1-E17K is oncogenic in lung epithelial cells
Marco, C. D., Malanga, D., Rinaldo, N., Vita, F. D., Scrima, M., Lovisa, S., Fabris, L., Carriero, M. V., Franco, R., Rizzuto, A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4022 · Cited by 32
DNA copy number loss and allelic imbalance at 2p16 in lung cancer associated with asbestos exposure
Kettunen, E., Aavikko, M., Nymark, P., Ruosaari, S., Wikman, H., Vanhala, E., Salmenkivi, K., Pirinen, R., Karjalainen, A., Kuosma, E., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605012 · Cited by 29
Yang, J., Shen, Y., Liu, B., & Yu, T. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.03.002 · Cited by 26
Crocidolite asbestos-induced signal pathway dysregulation in mesothelial cells
Wang, H., Gillis, A., Zhao, C., Lee, E., Wu, J. W., Zhang, F., Ye, F., & Zhang, D. Y. (2011) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2011.04.008 · Cited by 24
Inflammatory Cytokines Contribute to Asbestos-Induced Injury of Mesothelial Cells
Acencio, M. M. P., Soares, B., Marchi, E., Silva, C. S. R., Teixeira, L. R., & Broaddus, V. C. (2015) · Lung · doi:10.1007/s00408-015-9744-4 · Cited by 23 · cited 1×
“Exposure of cells to asbestos induces extensive alterations in expression of genes involved in integrinmediated signalling, DNA damage repair, and cell cycle regulation pathways.(43,44) The chronic inflammation caused by exposure of serosal surfaces to asbestos fibres is likely to represent a central factor in the car…”
BackgroundNymark, P. E. H., Aavikko, M., Mäkilä, J., Ruosaari, S., Hienonen-Kempas, T., Wikman, H., Salmenkivi, K., Pirinen, R. T., Karjalainen, A., Vanhala, E., et al. (2012) · Molecular Oncology · doi:10.1016/j.molonc.2012.07.006 · Cited by 22
Pietruska, J. R., Johnston, T., Zhitkovich, A., & Kane, A. B. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002312 · Cited by 22
Anti‑tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations
Ogoshi, Y., Shien, K., Yoshioka, T., Torigoe, H., Sato, H., Sakaguchi, M., Tomida, S., Namba, K., Kurihara, E., Takahashi, Y., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.9908 · Cited by 22
Miglio, U., Mezzapelle, R., Paganotti, A., Veggiani, C., Mercalli, F., Mancuso, G., Gaudino, E., Rena, O., Buosi, R., & Boldorini, R. L. (2015) · Diagnostic Cytopathology · doi:10.1002/dc.23319 · Cited by 21
Baldys, A., & Aust, A. E. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0133oc · Cited by 21
Auliac, J. B., Dô, P., Bayle, S., Doubre, H., Vinas, F., Letreut, J., Falchero, L., Hauss, P. A., Thomas, P. A., & CHOUAID, C. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01001-9 · Cited by 20
Fibroblast Growth Factor Receptor 1 Gene Amplification in Nonsmall Cell Lung Cancer
Miao, J., Liu, R., Zhou, J., & Meng, S.-H. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.194649 · Cited by 18
Heme‐related gene expression signatures of meat intakes in lung cancer tissues
Lam, T. K., Rotunno, M., Ryan, B. M., Pesatori, A. C., Bertazzi, P. A., Spitz, M. R., Caporaso, N. E., & Landi, M. T. (2013) · Molecular Carcinogenesis · doi:10.1002/mc.22006 · Cited by 17
Saint-Pierre, M., Pease, C., Mithoowani, H., Zhang, T., Nicholas, G. A., Laurie, S. A., & Wheatley‐Price, P. (2015) · Lung Cancer International · doi:10.1155/2015/590148 · Cited by 16
Epigenetic Biomarkers for the Early Detection of Gastrointestinal Cancer
Chen, H., & Fang, J. (2014) · Gastrointestinal Tumors · doi:10.1159/000380784 · Cited by 14
Ramazzini, C. (2015) · Scandinavian Journal of Work Environment & Health · doi:10.5271/sjweh.3535 · Cited by 14
Rivalland, G., Mitchell, P., Murone, C., Asadi, K., Morey, A. L., Starmans, M. H. W., Boutros, P. C., Walkiewicz, M., Solomon, B., Wright, G. M., et al. (2019) · Translational Lung Cancer Research · doi:10.21037/tlcr.2019.03.11 · Cited by 8
Histopathological data of iron and calcium in the mouse lung after asbestos exposure
Trevisan, E., Zabucchi, G., Pascolo, L., Pascotto, E., Casarsa, C., Lucattelli, M., Lungarella, G., Cavarra, E., Bartalesi, B., Zweyer, M., et al. (2016) · Data in Brief · doi:10.1016/j.dib.2016.01.026 · Cited by 5
Elgendy, A. (2020) · Radiopaedia.org · doi:10.53347/rid-74407 · Cited by 1
Cited by
Lee, H., Sam, K., Coulon, F., Gisi, S. D., Notarnicola, M., & Labianca, C. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.168769 · Cited by 140
Sex Differences in Lung Cancer
May, L., Shows, K. H., Nana-Sinkam, P. S., Li, H. Y., & Landry, J. W. (2023) · Cancers · doi:10.3390/cancers15123111 · Cited by 129
Reactive oxygen species (ROS): Critical roles in breast tumor microenvironment
Malla, R. R., Surepalli, N., Farran, B., Malhotra, S. V., & Nagaraju, G. P. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103285 · Cited by 118
The evolving landscape of sex-based differences in lung cancer: a distinct disease in women
Ragavan, M. V., & Patel, M. I. (2022) · European Respiratory Review · doi:10.1183/16000617.0100-2021 · Cited by 101
Gualtieri, A. F. (2021) · Current Research in Toxicology · doi:10.1016/j.crtox.2021.01.005 · Cited by 49
Metadata
- Authors
- Cheng, Y. Y., Rath, E. M., Linton, A., Yuen, M. L., Takahashi, K., & Lee, K.
- Affiliations
- The University of Sydney (AU)
- Garvan Institute of Medical Research (AU)
- Corresponding author
- Cheng, Yuen Yee
- Venue
- Lung Cancer Targets and Therapy
- Publisher
- Informa UK Limited
- Published
- 2020-01
- Volume
- Volume 11
- Pages
- 1-11
- ISSN
- 1179-2728 (ISSN-L)
- PMC
- PMC6955579
- OpenAlex
- W2999302779
- Cited by
- 31
- References
- 129
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 7 · 2022: 5 · 2021: 7 · 2020: 2
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Lung Cancer Targets and Therapy (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- asbestos, lung cancer, epigenetic modifications, DNA methylation, malignant mesothelioma, reactive oxygen species, tumor suppressor, promoter methylation, tumor markers, non-invasive cancer diagnosis, epigenetic therapy, occupational exposure, latency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.